Atlas Trials

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Clinical trial NCT00960518 · UNKNOWN

Trial details

NCT number
NCT00960518
Sponsor
Tongji University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B VirusHepatocellular Carcinoma
Start date
2009-08-01
Primary completion
2012-08-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.